Pd/C-catalyzed, copper-free Sonogashira coupling
889
NMR (100 MHz, DMSO-d6): d = 84.95, 96.35, 116.61,
120.60, 124.75, 126.02, 128.50, 129.68, 130.72, 131.29,
132.14, 132.85, 134.87, 135.97, 136.09, 145.33, 148.53,
149.46 ppm; MS (EI, 70 eV): m/z (%) = 391 ([M?], 100),
345 (40), 314 (47), 290 (18), 168 (29); HRMS (ESI):
m/z = 391.1047.
(100 MHz, DMSO-d6): d = 85.01, 96.20, 116.25, 120.63,
126.18, 127.49, 128.34, 129.68, 129.85, 130.60, 131.27,
132.45, 132.83, 136.03, 136.46, 136.80, 145.11, 149.14 ppm;
MS (EI, 70 eV): m/z (%) = 382 ([M?][37Cl], 32), 380
([M?][35Cl], 100), 345 (30), 303 (62), 279 (26), 168 (20);
HRMS (ESI): m/z = 380.0850.
1-(2-Fluorophenyl)-4-(2-phenylethynyl)[1,2,4]triazolo-
[4,3-a]quinoxaline (4e, C23H13FN4)
1-(2,6-Dichlorophenyl)-4-(2-phenylethynyl)[1,2,4]triazolo-
[4,3-a]quinoxaline (4i, C23H12Cl2N4)
White solid; yield 276 mg (76 %); m.p.: 305–307 °C;
White solid; yield 310 mg (75 %); m.p.: 267–269 °C;
Rf = 0.50; IR (KBr): m = 2,250, 1,570 cm-1 1H NMR
;
Rf = 0.57; IR (KBr): m = 2,210, 1,620 cm-1 1H NMR
;
(400 MHz, DMSO-d6): d = 7.20 (s, 1H), 7.35–7.43 (m,
4H), 7.57–7.64 (m, 4H), 7.82–7.86 (m, 2H), 8.21 (d,
J = 8.0 Hz, 2H) ppm; 13C NMR (100 MHz, DMSO-d6):
d = 85.80, 96.42, 116.62, 122.26, 122.92, 124.85, 127.70,
128.37, 128.81, 129.21, 130.35, 130.56, 133.51, 133.65,
141.52, 146.23, 146.56, 149.55, 160.42 ppm; MS (EI,
70 eV): m/z (%) = 364 ([M?], 100), 345 (27), 287 (62),
263 (42), 167 (25); HRMS (ESI): m/z = 364.1152.
(400 MHz, DMSO-d6): d = 7.20 (s, 1H), 7.40–7.48 (m,
4H), 7.55–7.62 (m, 3H), 7.75–7.78 (m, 2H), 8.12–8.15 (m,
1H), 8.17–8.20 (m, 1H) ppm; 13C NMR (100 MHz,
DMSO-d6): d = 85.35, 96.23, 127.80, 127.95, 128.44,
128.84, 128.92, 129.10, 129.25, 129.54, 130.92, 131.44,
132.35, 132.74, 133.55, 138.22, 142.62, 145.84, 149.12 ppm;
MS (EI, 70 eV): m/z (%) = 418 ([M?][37Cl2], 12), 416
([M?][37Cl][35Cl], 53), 414 ([M?][35Cl2], 100), 381 (23),
339 (65), 313 (30), 269 (32), 168 (15); HRMS (ESI):
m/z = 414.0475.
1-(4-Fluorophenyl)-4-(2-phenylethynyl)[1,2,4]triazolo-
[4,3-a]quinoxaline (4f, C23H13FN4)
White solid; yield 309 mg (85 %); m.p.: 313–315 °C;
Rf = 0.51; IR (KBr): m = 2,230, 1,590 cm-1 1H NMR
;
1-(4-Methylphenyl)-4-(2-phenylethynyl)[1,2,4]triazolo-
[4,3-a]quinoxaline (4j, C24H16N4)
(400 MHz, DMSO-d6): d = 7.20 (s, 1H), 7.35–7.41 (m,
2H), 7.55–7.62 (m, 2H), 7.78–7.82 (m, 2H), 7.90–7.98 (m,
4H), 8.15–8.19 (m, 2H) ppm; 13C NMR (100 MHz,
DMSO-d6): d = 85.82, 96.44, 116.36, 116.45, 122.32,
126.22, 127.32, 128.24, 128.55, 128.74, 128.92, 129.20,
130.35, 130.47, 132.10, 132.21, 142.30, 145.25, 149.25,
162.92 ppm; MS (EI, 70 eV): m/z (%) = 364 ([M?], 100),
345 (32), 287 (67), 263 (35), 167 (29); HRMS (ESI):
m/z = 364.1144.
White solid; yield 288 mg (80 %); m.p.: 218–220 °C;
Rf = 0.52; IR (KBr): m = 2,220, 1,600 cm-1 1H NMR
;
(400 MHz, DMSO-d6): d = 2.39 (s, 3H), 7.36 (d,
J = 8.0 Hz, 2H), 7.50–7.62 (m, 4H), 7.70–7.77 (m, 3H),
8.08–8.14 (m, 2H), 8.40–8.46 (m, 2H) ppm; 13C NMR
(100 MHz, DMSO-d6): d = 22.62, 85.12, 96.21, 116.25,
120.53, 124.62, 126.10, 128.42, 128.60, 129.52, 129.92,
130.62, 132.34, 132.45, 138.40, 140.92, 141.52, 145.22,
149.62 ppm; MS (EI, 70 eV): m/z (%) = 360 ([M?], 100),
345 (21), 283 (64), 259 (24), 168 (22); HRMS (ESI):
m/z = 360.1343.
1-(2-Chlorophenyl)-4-(2-phenylethynyl)[1,2,4]triazolo-
[4,3-a]quinoxaline (4g, C23H13ClN4)
White solid; yield 315 mg (83 %); m.p.: 276–278 °C;
Rf = 0.56; IR (KBr): m = 2,250, 1,600 cm-1 1H NMR
;
1-(4-Methoxyphenyl)-4-(2-phenylethynyl)[1,2,4]triazolo-
[4,3-a]quinoxaline (4k, C24H16N4O)
(400 MHz, DMSO-d6): d = 7.35 (s, 1H), 7.43–7.52 (m,
4H), 7.60–7.70 (m, 4H), 8.06–8.12 (m, 2H), 8.40 (d,
J = 8.0 Hz, 2H) ppm; 13C NMR (100 MHz, DMSO-d6):
d = 85.65, 96.53, 123.42, 127.53, 127.65, 128.21, 128.32,
128.42, 128.65, 129.25, 129.64, 130.36, 130.54, 132.25,
132.36, 132.46, 138.65, 142.35, 145.65, 149.58 ppm; MS
(EI, 70 eV): m/z (%) = 382 ([M?][37Cl], 31), 380
([M?][35Cl], 100), 345 (35), 303 (57), 279 (21), 167
(25); HRMS (ESI): m/z = 380.0850.
White solid; yield 304 mg (81 %); m.p.: 250–252 °C;
Rf = 0.51; IR (KBr): m = 2,200, 1,620 cm-1 1H NMR
;
(400 MHz, DMSO-d6): d = 3.90 (s, 3H), 7.20 (d,
J = 8.7 Hz, 2H), 7.41–7.52 (m, 3H), 7.54–7.62 (m, 3H),
7.67–7.70 (m, 1H), 7.75–7.81 (m, 2H), 8.06 (d,
J = 8.4 Hz, 2H) ppm; 13C NMR (100 MHz, DMSO-d6):
d = 55.92, 85.15, 96.20, 116.12, 122.36, 124.51, 126.15,
128.21, 128.42, 128.52, 128.95, 129.55, 129.78, 130.54,
132.32, 132.45, 140.48, 145.23, 149.65 ppm; MS (EI,
70 eV): m/z (%) = 376 ([M?], 100), 345 (21), 299 (64),
275 (27), 269 (32), 168 (27); HRMS (ESI): m/z =
376.1360.
1-(4-Chlorophenyl)-4-(2-phenylethynyl)[1,2,4]triazolo-
[4,3-a]quinoxaline (4h, C23H13ClN4)
White solid; yield 326 mg (86 %); m.p.: 289–291 °C;
Rf = 0.55; IR (KBr): m = 2,240, 1,600 cm-1 1H NMR
;
(400 MHz, DMSO-d6): d = 7.41–7.45 (m, 1H), 7.55–7.63
(m, 4H), 7.65–7.69 (m, 1H), 7.71–7.77 (m, 3H), 7.85 (d,
J = 8.0 Hz, 2H), 8.11–8.18 (m, 2H) ppm; 13C NMR
Acknowledgments We are grateful to the Research Council of
Shahrood University of Technology for the financial support of this
work.
123